D Keith Grossman's most recent trade in Outset Medical Inc was a trade of 8,983 Common Stock done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 8,983 | 13,918 | - | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.78 per share. | 11 Mar 2025 | 1,641 | 228,552 (0%) | 0% | 5.8 | 9,485 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 187,500 | 192,686 | - | - | Common Stock | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 750 | 0 | - | - | Series A Non-Voting Convertible Preferred | |
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 750 | 750 | - | - | Series A Non-Voting Convertible Preferred | |
| Nevro Corp | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,750 | 232,281 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 1,071 | 231,210 (0%) | 0% | 5.7 | 6,126 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.72 per share. | 28 Feb 2025 | 1,017 | 230,193 (0%) | 0% | 5.7 | 5,817 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.26 per share. | 03 Dec 2024 | 928 | 227,531 (0%) | 0% | 4.3 | 3,953 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.55 per share. | 03 Sep 2024 | 1,020 | 228,459 (0%) | 0% | 5.6 | 5,661 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 38,117 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 Jun 2024 | 38,117 | 85,922 | - | 1.1 | 42,310 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 Jun 2024 | 31,186 | 74,035 | - | 1.1 | 34,616 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 31,186 | 38,117 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 3.80 per share. | 03 Jun 2024 | 26,230 | 47,805 | - | 3.8 | 99,766 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 3.74 per share. | 03 Jun 2024 | 11,887 | 74,035 | - | 3.7 | 44,468 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.33 per share. | 03 Jun 2024 | 1,134 | 229,479 (0%) | 0% | 9.3 | 10,580 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 25,000 | 42,849 | - | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 19,169 | 230,613 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.12 per share. | 11 Apr 2024 | 3,986 | 211,444 (0%) | 0% | 13.1 | 52,296 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.99 per share. | 11 Mar 2024 | 2,184 | 215,430 (0%) | 0% | 15.0 | 32,738 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 4,750 | 219,211 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 04 Mar 2024 | 1,597 | 217,614 (0%) | 0% | 14.5 | 23,172 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.22 per share. | 03 Mar 2024 | 1,403 | 214,461 (0%) | 0% | 14.2 | 19,951 | Common Stock |
| Nevro Corp | Grossman D. Keith | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.82 per share. | 03 Dec 2023 | 2,056 | 215,864 (0%) | 0% | 18.8 | 38,694 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.75 per share. | 24 Oct 2023 | 6,012 | 217,920 (0%) | 0% | 15.8 | 94,689 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.39 per share. | 03 Sep 2023 | 2,193 | 223,932 (0%) | 0% | 20.4 | 44,715 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.16 per share. | 24 Jul 2023 | 6,013 | 226,125 (0%) | 0% | 24.2 | 145,274 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.27 per share. | 03 Jun 2023 | 2,193 | 232,138 (0%) | 0% | 28.3 | 61,996 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 7,681 | 17,849 | - | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 22,841 | 234,331 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.66 per share. | 11 Apr 2023 | 4,263 | 211,490 (0%) | 0% | 35.7 | 152,019 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.19 per share. | 11 Mar 2023 | 2,757 | 215,753 (0%) | 0% | 30.2 | 83,234 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.43 per share. | 03 Mar 2023 | 8,798 | 218,510 (0%) | 0% | 34.4 | 302,915 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 6,880 | 10,168 | - | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Apr 2022 | 4,263 | 227,308 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 147,644 | 309,305 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.08 per share. | 24 Mar 2022 | 77,734 | 231,571 (0%) | 0% | 67.1 | 5,214,397 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.61 per share. | 19 Mar 2022 | 4,875 | 161,661 (0%) | 0% | 70.6 | 344,224 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.09 per share. | 11 Mar 2022 | 2,754 | 166,536 (0%) | 0% | 64.1 | 176,504 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Purchase of securities on an exchange or from another person at price $ 63.59 per share. | 08 Mar 2022 | 3,200 | 169,290 (0%) | 0% | 63.6 | 203,488 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 50,000 | 166,090 (0%) | 0% | 0 | Common Stock | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 01 Dec 2021 | 1,296 | 5,186 | - | 47.9 | 62,104 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 01 Nov 2021 | 2,592 | 7,778 | - | 55 | 142,560 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 54.31 per share. | 01 Nov 2021 | 1,296 | 6,482 | - | 54.3 | 70,386 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 49.69 per share. | 01 Oct 2021 | 1,234 | 2,054 | - | 49.7 | 61,317 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 62 | 69,303 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 01 Oct 2021 | 62 | 3,350 | - | 1.1 | 69 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 49.69 per share. | 01 Oct 2021 | 62 | 3,288 | - | 49.7 | 3,081 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.63 per share. | 19 Sep 2021 | 4,874 | 120,964 (0%) | 0% | 126.6 | 617,195 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 1,296 | 71,957 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 1,296 | 70,661 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 1,296 | 69,365 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 17 Sep 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 17 Sep 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 17 Sep 2021 | 1,296 | 3,288 | - | 55 | 71,280 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 17 Sep 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 17 Sep 2021 | 1,296 | 3,288 | - | 55 | 71,280 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 17 Sep 2021 | 1,296 | 3,288 | - | 55 | 71,280 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 17 Sep 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 17 Sep 2021 | 1,296 | 3,288 | - | 55 | 71,280 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 1,296 | 73,253 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 1,296 | 74,549 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 49.17 per share. | 01 Sep 2021 | 1,296 | 3,288 | - | 49.2 | 63,721 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 01 Sep 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 1,296 | 75,845 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 26 Aug 2021 | 1,296 | 3,288 | - | 45 | 58,320 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 26 Aug 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Purchase of securities on an exchange or from another person at price $ 105.07 per share. | 13 Aug 2021 | 7,000 | 125,838 (0%) | 0% | 105.1 | 735,490 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,296 | 77,141 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 49.23 per share. | 01 Jul 2021 | 1,296 | 3,288 | - | 49.2 | 63,804 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 01 Jul 2021 | 1,296 | 4,584 | - | 1.1 | 1,439 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.45 per share. | 19 Jun 2021 | 4,874 | 118,838 (0%) | 0% | 160.4 | 782,033 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 3,288 | 3,288 | - | 0 | Common Stock | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,296 | 78,437 | - | - | Non-Qualified Stock Option (right to buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 01 Jun 2021 | 1,296 | 0 | - | 47.9 | 62,102 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 01 Jun 2021 | 1,296 | 1,296 | - | 1.1 | 1,439 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 03 May 2021 | 2,592 | 2,592 | - | 1.1 | 2,877 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 2,592 | 79,733 | - | - | Stock Option (Right to Buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 57.87 per share. | 03 May 2021 | 2,274 | 318 | - | 57.9 | 131,603 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 59.79 per share. | 03 May 2021 | 218 | 0 | - | 59.8 | 13,034 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 58.50 per share. | 03 May 2021 | 100 | 218 | - | 58.5 | 5,850 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.08 per share. | 11 Apr 2021 | 4,263 | 123,712 (0%) | 0% | 147.1 | 627,002 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 01 Apr 2021 | 2,592 | 0 | - | 55.1 | 142,721 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 2,592 | 82,325 | - | - | Stock Option (Right to Buy) | |
| Outset Medical Inc | D. Keith Grossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.11 per share. | 01 Apr 2021 | 2,592 | 2,592 | - | 1.1 | 2,877 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.81 per share. | 19 Mar 2021 | 4,873 | 127,975 (0%) | 0% | 142.8 | 695,913 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2021 | 20,953 | 132,848 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 181.23 per share. | 19 Dec 2020 | 4,998 | 111,895 (0%) | 0% | 181.2 | 905,788 | Common Stock |
| Nevro Corp | D. Keith Grossman | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.50 per share. | 19 Sep 2020 | 4,998 | 116,893 (0%) | 0% | 142.5 | 712,215 | Common Stock |
| Outset Medical Inc | D. Keith Grossman | Director | 17 Sep 2020 | 38,588 | 0 | - | - | Series C Redeemable Convertible Preferred Stock | ||
| Outset Medical Inc | D. Keith Grossman | Director | 17 Sep 2020 | 32,155 | 0 | - | - | Series D Redeemable Convertible Preferred Stock | ||
| Outset Medical Inc | D. Keith Grossman | Director | 17 Sep 2020 | 10,257 | 11,604 | - | - | Common Stock |